You are here

Article info

Article menu

Download PDFPDF

XML
Basic tumor immunology
Original research
Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy

Authors

  • Yan Wang Gustave Roussy Cancer Campus, Villejuif, France INSERM, UMR1138, Centre de Recherche des Cordeliers, Paris, France Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France Université de Paris, Paris, France Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France Sorbonne Université, Paris, France Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Wei Xie Gustave Roussy Cancer Campus, Villejuif, France INSERM, UMR1138, Centre de Recherche des Cordeliers, Paris, France Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France Université de Paris, Paris, France Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France Sorbonne Université, Paris, France Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France PubMed articlesGoogle scholar articles
  • Juliette Humeau Gustave Roussy Cancer Campus, Villejuif, France INSERM, UMR1138, Centre de Recherche des Cordeliers, Paris, France Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France Université de Paris, Paris, France Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France Sorbonne Université, Paris, France Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France PubMed articlesGoogle scholar articles
  • Guo Chen Gustave Roussy Cancer Campus, Villejuif, France INSERM, UMR1138, Centre de Recherche des Cordeliers, Paris, France Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France Université de Paris, Paris, France Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France Sorbonne Université, Paris, France Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France College of Life Sciences, Nankai University, Tianjin, China PubMed articlesGoogle scholar articles
  • Peng Liu Gustave Roussy Cancer Campus, Villejuif, France INSERM, UMR1138, Centre de Recherche des Cordeliers, Paris, France Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France Université de Paris, Paris, France Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France Sorbonne Université, Paris, France Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France PubMed articlesGoogle scholar articles
  • Jonathan Pol Gustave Roussy Cancer Campus, Villejuif, France INSERM, UMR1138, Centre de Recherche des Cordeliers, Paris, France Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France Université de Paris, Paris, France Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France Sorbonne Université, Paris, France Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France PubMed articlesGoogle scholar articles
  • Zhen Zhang Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China PubMed articlesGoogle scholar articles
  • Oliver Kepp Gustave Roussy Cancer Campus, Villejuif, France INSERM, UMR1138, Centre de Recherche des Cordeliers, Paris, France Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France Université de Paris, Paris, France Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France Sorbonne Université, Paris, France Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France PubMed articlesGoogle scholar articles
  • Guido Kroemer Gustave Roussy Cancer Campus, Villejuif, France INSERM, UMR1138, Centre de Recherche des Cordeliers, Paris, France Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France Université de Paris, Paris, France Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France Sorbonne Université, Paris, France Faculté de Médecine, Université Paris-Saclay, Kremlin-Bicêtre, France Pôle de Biologie, Paris, France, Hôpital Européen Georges Pompidou, AP-HP, Paris, France Suzhou Institute for Systems Medicine, Chinese Academy of Sciences, Suzhou, China Department of Women’s and Children’s Health, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Oliver Kepp; captain.olsen{at}gmail.com; Professor Zhen Zhang; zhen_zhang{at}fudan.edu.cn; Guido Kroemer; kroemer{at}orange.fr
View Full Text

Citation

Wang Y, Xie W, Humeau J, et al
Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy
Journal for ImmunoTherapy of Cancer 2020;8:e000462. doi: 10.1136/jitc-2019-000462

Publication history

  • Accepted March 11, 2020
  • First published March 26, 2020.
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.